A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (6) , 1654-1669
- https://doi.org/10.1016/s0149-2918(03)80161-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal TransplantationAmerican Journal of Transplantation, 2002
- COMPARISON OF MICROEMULSION AND CONVENTIONAL FORMULATIONS OF CYCLOSPORINE A IN PREVENTING ACUTE REJECTION IN DE NOVO KIDNEY TRANSPLANT PATIENTS1Transplantation, 1999
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- PEAK CYCLOSPORINE LEVELS (Cmax) CORRELATE WITH FREEDOM FROM LIVER GRAFT REJECTIONTransplantation, 1999
- RANDOMIZED TRIAL OF CYCLOSPORINE MICROEMULSION (NEORAL) VERSUS CONVENTIONAL CYCLOSPORINE IN LIVER TRANSPLANTATIONTransplantation, 1998
- Cyclosporin Pharmacokinetics in Paediatric Transplant RecipientsClinical Pharmacokinetics, 1997
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- REVERSAL OF CYCLOSPORINE MALABSORPTION IN DIABETIC RECIPIENTS OF SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTS USING A MICROEMULSION FORMULATIONTransplantation, 1996
- CYCLOSPORINE BIOAVAILABILITY IN HEART-LUNG TRANSPLANT CANDIDATES WITH CYSTIC FIBROSISTransplantation, 1990
- Cyclosporine Kinetics in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987